References
- Thadani U, Fung HL, Darke AC, et al. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action and dose-response relation during acute and sustained therapy. Am J Cardiol 1982: 49(2): 411–9
- Parker JO, Fung HL. Transdermal nitroglycerin in angina pectoris. Am J Cardiol 1984: 54(6): 471–6
- Thadani U, Hamilton SF, Olson E, et al. Transdermal nitroglycerin patches in angina pectoris: dose titration, duration of effect, and rapid tolerance. Ann Intern Med 1986: 105(4): 485–92
- Elkayam U, Kulick D, McIntosh N, et al. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation 1987: 76(3): 577–84
- Abrams J. Tolerance to organic nitrates. Circulation 1986: 74(6): 1181–5
- Jordan RA, Seth L, Casebolt P, et al. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. Ann Intern Med 1986: 104(3): 295–8
- Flaherty JT. Nitrate tolerance: a review of the evidence. Drugs 1989: 37(4): 523–50
- Thadani U, Whitsett T, Hamilton SF. Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance. Curr Probl Cardiol 1988: 13(11): 723–84
- Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 1991: 114(8): 667–77
- Thadani U. Nitrate therapy in unstable angina pectoris. In: Bleifeld W Hamm CW, Braunwald E, eds. Unstable angina. New York: Springer-Verlag, 1990: 203–13
- Steering Committee, Transdermal Nitroglycerin Cooperative Study. Acute and chronic antianginal efficacy of continuous 24-hour application of transdermal nitroglycerin. Am J Cardiol 1991: 68;1263–73
- Zimrin D, Reichek N, Bogin KT, et al. Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 1988: 77(6): 1376–84
- Parker JO, Farrell B, Lahey KA, et al. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate. N Engl J Med 1987: 316(23): 1440–4
- Bassan MM. The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate. J Am Coll Cardiol 1990: 16(4): 936–40
- Thadani U, IS-5MN Study Group. Isosorbide-5-mononitrate (IS-5MN) in angina pectoris: efficacy of a.m. and p.m. doses, lack of tolerance and zero hour effect during chronic eccentric bid therapy. (Abstr) Circulation 1991: 84(suppl II): 11–730
- DeMots H, Glasser SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol 1989: 13(4): 786–95
- Packer M, Lee WH, Kessler PD, et al. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987: 317(13): 799–804
- Leier CV, Huss P, Magorien RD, et al. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation 1983: 67(4): 817–22
- Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991: 325(5): 303–10
- Dupuis J, Lalonde G, Lemieux R, et al. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylysteine. J Am Coll Cardiol 1990: 16(4): 923–31